← Back to SGP

SpyGlass Pharma, Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 06/08/2026Mar 2026Filed 06/08/2026Jun 2025Filed 06/08/2026Mar 2025Filed 06/08/2026
−$20−$14−$8.7−$8.8
−$0.59−$0.69−$3.81−$3.96
33202.32.2

Trend

Net income

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.